Stock Earnings

Question 1

What are Avenue Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Avenue Therapeutics Inc has a total asset of $2, Net loss of $-11

Question 2

What are the key financial ratios for ATXI?

Accepted Answer

Avenue Therapeutics Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

Question 3

How is Avenue Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Avenue Therapeutics Inc data is not available.

Question 4

Is Avenue Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Avenue Therapeutics Inc has a net loss of $-11

Question 5

Does Avenue Therapeutics Inc have any liabilities?

Accepted Answer

no, Avenue Therapeutics Inc has liability of 0

Question 6

How many outstanding shares for Avenue Therapeutics Inc?

Accepted Answer

Avenue Therapeutics Inc has a total outstanding shares of 2.1

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	4	4	4	5	2	2
Research & Development	3	6	10	2	1	2
Operating Expenses	7	11	14	8	3	5
Other Non Operating Income (Expenses)	0	0	4	5	--	--
Pretax Income	-6	-11	-10	-3	-3	-5
Income Tax Expense	--	--	--	--	--	--
Net Income	-6	-11	-10	-3	-3	-5
Net Income Growth	20%	10%	233%	0%	-40%	-80%
Shares Outstanding (Diluted)	3.18	1.29	0.14	0.02	0.01	0.01
Shares Change (YoY)	184%	817%	385%	93%	3%	5%
EPS (Diluted)	-1.92	-8.99	-73.5	-122.06	-247.08	-350.4
EPS Growth	-63%	-88%	-40%	-51%	-28.99%	-81%
Free Cash Flow	-5	-9	-9	-7	-3	-4
Free Cash Flow Per Share	-1.57	-6.94	-63.73	-240.54	-198.67	-272.1
Gross Margin	--	--	--	--	--	--
Operating Margin	-600%	0%	0%	0%	0%	0%
Profit Margin	-600%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-500%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-6	-11	-14	-8	-3	-5
EBIT Margin	-600%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Avenue Therapeutics Inc (ATXI) Price